Clinical Trials in Dallas

Showing 1841-1860 of 17,468 trials

An Observational Study of Patients With Chronic Liver Disease

NCT05744713

TARGET-Liver Disease (TARGET-LD) is an observational research study to conduct a comprehensive review of outcomes for patients with chronic liver disease (CLD).

Chronic Liver DiseaseCirrhosis

Target PharmaSolutions, Inc.500,000 participantsStarted Feb 2024

Los Angeles, California, United States • Redwood City, California, United States • Washington D.C., District of Columbia, United States +7 more locations

RECRUITINGPhase 3< 1 mile

A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis

NCT04951622

The purpose of this study is to evaluate the efficacy and safety of nipocalimab compared to placebo in participants with generalized myasthenia gravis (gMG). The purpose of the subcutaneous substudy is to evaluate how well it works in the body (pharmacodynamic \[PD\]) when given as an injection under the skin (subcutaneous) compared to when given through a vein (intravenous) in participants with gMG.

Myasthenia Gravis

Janssen Research & Development, LLC199 participantsStarted Jul 2021

Paradise Valley, Arizona, United States • Scottsdale, Arizona, United States • Los Angeles, California, United States +109 more locations

An Observational Study of Patients With Chronic Liver Disease

A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis

Find Trials by Condition in Dallas

Zilebesiran as Add-on Therapy in Patients With High Cardiovascular Risk and Hypertension Not Adequately Controlled by Standard of Care Antihypertensive Medications (KARDIA-3)

Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery

A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors

Comparing Two Treatment Combinations, Gemcitabine and Nab-Paclitaxel With 5-Fluorouracil, Leucovorin, and Liposomal Irinotecan for Older Patients With Pancreatic Cancer That Has Spread

A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease (NPC)

A Study of Sotatercept in Participants With PAH WHO FC III or FC IV at High Risk of Mortality (MK-7962-006/ZENITH)

Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid Tumors

A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer

A Study of Safety and Immune Response to Different Doses of a Cytomegalovirus Vaccine in Healthy Adults

Efficacy, Safety and Tolerability of AZD6234 in Participants Living With Overweight or Obesity With Type 2 Diabetes Who Are on a Stable Dose of GLP-1 Receptor Agonist

Water Vapor Ablation for Localized Intermediate Risk Prostate Cancer

Evaluation of Efficacy and Safety of AR882 and XOI Co-administration in Uricase Treatment Failed Patients

Phase 2/Phase 3 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant

Mobile Health for Adherence in Breast Cancer Patients

Long Term Safety & Efficacy Study Evaluating The Effect of A4250 in Children With PFIC

ADVENT Post Approval Study

A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma

Bracing in Adolescent Idiopathic Scoliosis Trial (BrAIST)